Appointment booking for Dr. Fehmida Zahabi, MD is currently not available.Dr. Fehmida Zahabi, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Fehmida Zahabi, MD (she/her) is a Rheumatologist in Plano, TX with over 18 years of experience. What is your opinion of Dr. Fehmida Zahabi, MD? Rate this provider below so other people can make informed decision.
Gender
Female
Experience
Over 18 Years of Experience
Languages Spoken
English
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Fehmida Zahabi, MD has received over $35,662 which includes payments from the following companies:
$4,886.70 from UCB, Inc.
$4,298.02 from Janssen Biotech, Inc.
$3,943.64 from Oxford Immunotec Inc.
$3,132.62 from AbbVie, Inc.
$2,734.99 from Pfizer Inc.
$2,695.04 from Amgen Inc.
$2,506.50 from E.R. Squibb & Sons, L.L.C.
$1,799.90 from Genentech USA, Inc.
$1,370.12 from Celgene Corporation
$1,315.59 from GlaxoSmithKline, LLC.
$1,071.27 from LILLY USA, LLC
$1,022.36 from Novartis Pharmaceuticals Corporation
$766.69 from Janssen Scientific Affairs, LLC
$738.16 from Mallinckrodt LLC
$564.40 from Horizon Pharma plc
$529.06 from GENZYME CORPORATION
$295.34 from Flexion Therapeutics, Inc.
$272.37 from MEDAC PHARMA, INC.
$253.18 from Mallinckrodt Enterprises LLC
$242.91 from Radius Health, Inc.
Payments received by Dr. Fehmida Zahabi, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!